ID | CAS | Name | Synonyms | Molecular Formula | Category |
---|---|---|---|---|---|
1 | 1323077-89-9 | Enzaplatovir | BTA-585 BTA-C585) Enzaplatovir Enzaplatovir(BTA585 | ||
2 | 1423803-24-0 | Apixaban Impurity 17 | Apixaban Impurity 17 Apixaban Impurity 62 6-(4-Aminophenyl)-4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxamide 1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 6-(4-aminophenyl)-4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo- | ||
3 | 712297-58-0 | 6,7-dimethoxy-3-[1-(4-methoxyphenyl)-1H-tetraazol-5-yl]-4-methylquinoline | 6,7-dimethoxy-3-[1-(4-methoxyphenyl)-1H-tetraazol-5-yl]-4-methylquinoline | ||
4 | 932957-69-2 | 2-furyl-N-{3-methoxy-4-[(1-phenyl-1H-tetraazol-5-yl)oxy]benzyl}methanamine | 2-furyl-N-{3-methoxy-4-[(1-phenyl-1H-tetraazol-5-yl)oxy]benzyl}methanamine 1-(furan-2-yl)-N-{3-methoxy-4-[(1-phenyl-1H-tetrazol-5-yl)oxy]benzyl}methanamine | ||
5 | 957487-38-6 | 3-[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]-N'-{4-nitrobenzylidene}benzohydrazide | 3-[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]-N'-{4-nitrobenzylidene}benzohydrazide | ||
6 | 886546-07-2 | 4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-N-(3,4,5-trimethoxyphenyl)- -2-Pyrimidinamine, | 4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-N-(3,4,5-trimethoxyphenyl)- -2-Pyrimidinamine, | ||
7 | 1006674-23-2 | N'-{[3-(4-ethylphenyl)-1H-pyrazol-4-yl]methylene}-2-{4-nitrophenyl}acetohydrazide | N'-{[3-(4-ethylphenyl)-1H-pyrazol-4-yl]methylene}-2-{4-nitrophenyl}acetohydrazide | ||
8 | 1415564-51-0 | (2-(7-(3,4-dimethoxyphenyl)imidazo[1,2-c]pyrimidin-5-ylamino)pyridin-3-yl)methanol | (2-(7-(3,4-diMethoxyphenyl)iMidazo[1,2-c]pyriMidin-5-ylaMino)pyridin-3-yl)Methanol (2-(7-(3,4-dimethoxyphenyl)imidazo[1,2-c]pyrimidin-5-ylamino)pyridin-3-yl)methanol 3-Pyridinemethanol, 2-[[7-(3,4-dimethoxyphenyl)imidazo[1,2-c]pyrimidin-5-yl]amino]- | ||
9 | 4-(2-aminoanilino)-1-(2,5-dimethoxybenzyl)-2-oxo-1,2-dihydropyrimidine-5-carbonitrile | 4-(2-aminoanilino)-1-(2,5-dimethoxybenzyl)-2-oxo-1,2-dihydropyrimidine-5-carbonitrile | |||
10 | 457951-22-3 | benzyl 7-(4-methoxyphenyl)-5-methyl-4,7-dihydrotetraazolo[1,5-a]pyrimidine-6-carboxylate | benzyl 7-(4-methoxyphenyl)-5-methyl-4,7-dihydrotetraazolo[1,5-a]pyrimidine-6-carboxylate | ||
11 | methyl 7-[4-(benzyloxy)phenyl]-5-methyl-4,7-dihydrotetraazolo[1,5-a]pyrimidine-6-carboxylate | methyl 7-[4-(benzyloxy)phenyl]-5-methyl-4,7-dihydrotetraazolo[1,5-a]pyrimidine-6-carboxylate | |||
12 | (4Z)-3,4-Dihydro-4-[(2-acetylphenylazo)methylene]-1,2,3-benzotriazine-3-acetic acid ethyl ester | (4Z)-3,4-Dihydro-4-[(2-acetylphenylazo)methylene]-1,2,3-benzotriazine-3-acetic acid ethyl ester | |||
13 | 1434161-29-1 | 3H-Pyrrol-3-one, 5-amino-1-(3,5-dimethoxyphenyl)-1,2-dihydro-4-(3-phenyl-1H-1,2,4-triazol-5-yl)- | 3H-Pyrrol-3-one, 5-amino-1-(3,5-dimethoxyphenyl)-1,2-dihydro-4-(3-phenyl-1H-1,2,4-triazol-5-yl)- 5-amino-1-(3,5-dimethoxyphenyl)-4-(3-phenyl-1H-1,2,4-triazol-5-yl)-1,2-dihydro-3H-pyrrol-3-one | ||
14 | 1160521-51-6 | 7-[(4-Methoxyphenyl)methyl]-5-methyl-3-(phenylamino)-2H-pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione | 3-Anilino-7-[(4-methoxyphenyl)methyl]-5-methyl-2H-pyrazolo[3,4-d]pyrimidine-4,6-dione 7-(4-Methoxybenzyl)-5-Methyl-3-(Phenylamino)-2H-Pyrazolo[3,4-D]Pyrimidine-4,6(5H,7H)-Dione 7-[(4-Methoxyphenyl)methyl]-5-methyl-3-(phenylamino)-2H-pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione 2H-Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione, 7-[(4-methoxyphenyl)methyl]-5-methyl-3-(phenylamino)- | ||
15 | 488783-74-0 | ethyl 6-amino-5,7,7-tricyano-8-(5-methyl-2-furyl)-3,7,8,8a-tetrahydro-2(1H)-isoquinolinecarboxylate | ethyl 6-amino-5,7,7-tricyano-8-(5-methyl-2-furyl)-3,7,8,8a-tetrahydro-2(1H)-isoquinolinecarboxylate | ||
16 | N-METHYL-1-{[(1Z)-(4-METHYLPHENYL)METHYLENE]AMINO}-5-(2-OXO-2-PHENYLETHOXY)-1H-1,2,3-TRIAZOLE-4-CARBOXAMIDE | N-METHYL-1-{[(1Z)-(4-METHYLPHENYL)METHYLENE]AMINO}-5-(2-OXO-2-PHENYLETHOXY)-1H-1,2,3-TRIAZOLE-4-CARBOXAMIDE TOSLAB 35334 | |||
17 | 1622848-92-3 | (S)-5-Benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b]-[1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide | 5184 CS-2502 GSK2982772 GSK 2982772 GSK-2982772 RIP1 inhibitor GS2982772 (S)-5-BENZYL-N-(5-METHYL-4-OXO-2,3,4,5-TETRAHYDROBENZO[B][1,4]OXAZEPIN-3-YL)-4H-1,2,4-TRIAZOLE-3-CAR (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide (S)-5-Benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b]-[1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide 1H-1,2,4-Triazole-5-carboxamide, 3-(phenylmethyl)-N-[(3S)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl]- | ||
18 | 2004659-83-8 | Sorafenib impurity 24/N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide | Sorafenib impurities3 Sorafenib impurities164 Sorafenib tosylate Impurity T N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide | ||
19 | 1323077-88-8 | 1H,5H-Imidazo[1,2-a]pyrrolo[1,2-d]pyrazin-5-one, 2,3,10,10a-tetrahydro-1-[(3-methyl-4-isoxazolyl)carbonyl]-10a-(6-methyl-3-pyridinyl)-, (10aS)- | 1H,5H-Imidazo[1,2-a]pyrrolo[1,2-d]pyrazin-5-one, 2,3,10,10a-tetrahydro-1-[(3-methyl-4-isoxazolyl)carbonyl]-10a-(6-methyl-3-pyridinyl)-, (10aS)- |
ID | CAS | Product Name | Suppliers | Descriptions |
---|